Data updated: Mar 10, 2026
SUTAB
MAGNESIUM SULFATE
Approved 2020-11-10
1
Indication
--
Phase 3 Trials
5
Years on Market
Details
- Status
- Prescription
- First Approved
- 2020-11-10
- Routes
- ORAL
- Dosage Forms
- TABLET
Companies
Website: โ
SUTAB Approval History
Loading approval history...
What SUTAB Treats
1 FDA approvalsOriginally approved for its first indication in 2020 .
- Other (1)
๐ฌ
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
โญ
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
๐
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
SUTAB FDA Label Details
ProIndications & Usage
FDA Label (PDF)SUTAB is indicated for the cleansing of the colon as a preparation for colonoscopy in adults. SUTAB is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adults.
SUTAB Patents & Exclusivity
Latest Patent: Aug 2037
Patents (4 active)
US11382864
Expires Aug 4, 2037
US11033498
Expires Aug 4, 2037
US11638697
Expires Aug 4, 2037
US10143656
Expires Aug 4, 2037
Source: FDA Orange Book
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
FDA Approval: NDA213135 โ Label: DailyMed โ Patents: FDA Orange Book โ Trials: ClinicalTrials.gov โ
Data sourced from official FDA and NIH databases. Click links to verify on original sources.